Skip to main content
Top
Published in: Clinical Reviews in Allergy & Immunology 1-2/2007

01-10-2007

Chronic Urticaria: Recent Advances

Authors: Malcolm W. Greaves, Kian Teo Tan

Published in: Clinical Reviews in Allergy & Immunology | Issue 1-2/2007

Login to get access

Abstract

Chronic urticaria is an umbrella term, which encompasses physical urticarias, chronic “idiopathic” urticaria and urticarial vasculitis. It is important to recognize patients with physical urticarias as the investigation and treatment differs in important ways from patients with idiopathic chronic urticaria or urticarial vasculitis. Although relatively uncommon, urticarial vasculitis is an important diagnosis to make and requires histological confirmation by biopsy. Underlying systemic disease and systemic involvement, especially of the kidneys, should be sought. It is now recognized that chronic “idiopathic” urticaria includes a subset with an autoimmune basis caused by circulating autoantibodies against the high affinity IgE receptor (FceR1) and less commonly against IgE. Although the autologous serum skin test has been proven useful in prompting search for and characterization of circulating wheal-producing factors in chronic urticaria, its specificity as a screening test for presence of functional anti-FceR1 is low, and confirmation by demonstration of histamine-releasing activity in the patient’s serum must be the benchmark test in establishing this diagnosis. Improved screening tests are being sought; for example, ability of the chronic urticaria patient’s serum to evoke expression of CD 203c on donor human basophils is showing some promise. The strong association between autoimmune thyroid disease and autoimmune urticaria is also an area of ongoing research. Drug treatment continues to be centered on the H1 antihistamines, and the newer second-generation compounds appear to be safe and effective even in off-label dosage. Use of systemic steroids should be confined to special circumstances such as tapering regimens for acute flare-ups. Use of leukotriene antagonists is becoming popular, but the evidence for efficacy is conflicting. Cyclosporin is also effective and can be used in selected cases of autoimmune urticaria, and it is also effective in non-autoimmune cases, although less so.
Literature
1.
go back to reference Sheldon JM, Mathews KP, Lovell RG (1954) The vexing urticaria problem : present concepts of etiology and management. J Allergy 25:525–560PubMedCrossRef Sheldon JM, Mathews KP, Lovell RG (1954) The vexing urticaria problem : present concepts of etiology and management. J Allergy 25:525–560PubMedCrossRef
2.
go back to reference Champion RH, Roberts SOB, Carpenter RG, Roger JH (1969) Urticaria and angioedema: a review of 554 patients. Br J Dermatol 81:588–597PubMedCrossRef Champion RH, Roberts SOB, Carpenter RG, Roger JH (1969) Urticaria and angioedema: a review of 554 patients. Br J Dermatol 81:588–597PubMedCrossRef
3.
go back to reference Zuberbier T, Bindslev-Jensen C, Canonica W et al (2005) EAACI/GA2LEN/EDF guideline: definition, classification and diagnosis of urticaria Allergy Zuberbier T, Bindslev-Jensen C, Canonica W et al (2005) EAACI/GA2LEN/EDF guideline: definition, classification and diagnosis of urticaria Allergy
4.
go back to reference O’Donnell BF, Lawlor F, Simpson J et al (1997) The impact of chronic urticaria on quality of life. Br J Dermatol 136:553–556CrossRef O’Donnell BF, Lawlor F, Simpson J et al (1997) The impact of chronic urticaria on quality of life. Br J Dermatol 136:553–556CrossRef
5.
go back to reference Sabroe RA, Seed PT, Francis DM et al (1999) Chronic idiopathic urticaria : comparison of clinical features of patients with and without anti-FcɛR1 or anti-IgE autoantibodies. J Amer Acad Dermatol 40:443–450CrossRef Sabroe RA, Seed PT, Francis DM et al (1999) Chronic idiopathic urticaria : comparison of clinical features of patients with and without anti-FcɛR1 or anti-IgE autoantibodies. J Amer Acad Dermatol 40:443–450CrossRef
6.
go back to reference O’Donnell BF, Black AK (1995) Urticarial Vasculitis Int Angiol 14:166–174 O’Donnell BF, Black AK (1995) Urticarial Vasculitis Int Angiol 14:166–174
7.
go back to reference Black AK (2004) Physical urticarias. In: Greaves MW, Kaplan AP (eds) Urticaria and Angioedema. Marcel Dekker, NY Black AK (2004) Physical urticarias. In: Greaves MW, Kaplan AP (eds) Urticaria and Angioedema. Marcel Dekker, NY
8.
go back to reference Grattan CEH, Boon AP, Eady RAJ, Winkelmann RK (1990) The pathology of the autologous serum skin test response in chronic urticaria resembles IgE-mediated late phase reactions. Int Arch Allergy Immunol 93:198–204CrossRef Grattan CEH, Boon AP, Eady RAJ, Winkelmann RK (1990) The pathology of the autologous serum skin test response in chronic urticaria resembles IgE-mediated late phase reactions. Int Arch Allergy Immunol 93:198–204CrossRef
9.
go back to reference Frandji P et al (1998) IL-4 mRNA transcription is induced in mouse bone marrow-derived mast cells through an MHC class11-dependent signaling pathway. Eur J Immunol 28:844–855PubMedCrossRef Frandji P et al (1998) IL-4 mRNA transcription is induced in mouse bone marrow-derived mast cells through an MHC class11-dependent signaling pathway. Eur J Immunol 28:844–855PubMedCrossRef
10.
go back to reference Michaelsson G, Juhlin L (1973) Urticaria induced by preservatives and dye additives in food and drugs. Br J Dermatol 88:525–532PubMedCrossRef Michaelsson G, Juhlin L (1973) Urticaria induced by preservatives and dye additives in food and drugs. Br J Dermatol 88:525–532PubMedCrossRef
11.
go back to reference Greaves MW (2001) Chronic idiopathic urticaria and H pylori: not directly causative but could there be a link? ACI International 13:23–26 Greaves MW (2001) Chronic idiopathic urticaria and H pylori: not directly causative but could there be a link? ACI International 13:23–26
12.
go back to reference Rorsman H (1962) Basophilic leucopenia in different forms of urticaria. Acta Allergologica 17:168–184PubMed Rorsman H (1962) Basophilic leucopenia in different forms of urticaria. Acta Allergologica 17:168–184PubMed
13.
go back to reference Leznoff A, Sussman GL (1989) Syndrome of idiopathic chronic urticaria and angioedema with thyroid autoimmunity: a study of 90 patients. J Allergy Clin Immunol 84:66–71PubMedCrossRef Leznoff A, Sussman GL (1989) Syndrome of idiopathic chronic urticaria and angioedema with thyroid autoimmunity: a study of 90 patients. J Allergy Clin Immunol 84:66–71PubMedCrossRef
14.
go back to reference Hide M, Francis DM, Grattan CEH et al (1993) Autoantibodies against the high affinity IgE receptor as acause for histamine release in chronic urticaria. New Eng J Med 328:1599–1604PubMedCrossRef Hide M, Francis DM, Grattan CEH et al (1993) Autoantibodies against the high affinity IgE receptor as acause for histamine release in chronic urticaria. New Eng J Med 328:1599–1604PubMedCrossRef
15.
go back to reference Nimii N, Francis DM, Kermani F et al (1996) Dermal mast cell activation by autoantibody against the high affinity IgE receptor in chronic urticaria. J Invest Dermatol 106:1001–1006CrossRef Nimii N, Francis DM, Kermani F et al (1996) Dermal mast cell activation by autoantibody against the high affinity IgE receptor in chronic urticaria. J Invest Dermatol 106:1001–1006CrossRef
16.
go back to reference Fiebiger E, Maurer D, Holub H et al (1995) Autoantibodies directed against the α-chain of Fcepsilon R1; a selective marker and pathogenetic factor for a distinct subset of chronic urticaria patients. J Clin Invest 96:2606–2612PubMed Fiebiger E, Maurer D, Holub H et al (1995) Autoantibodies directed against the α-chain of Fcepsilon R1; a selective marker and pathogenetic factor for a distinct subset of chronic urticaria patients. J Clin Invest 96:2606–2612PubMed
17.
go back to reference Tong LJ, Balakrishnan G, Kochan JP et al (1997) Assessment of autoimmunity in patients with chronic urticaria. J Allergy Clin Immunol 99:461–465PubMedCrossRef Tong LJ, Balakrishnan G, Kochan JP et al (1997) Assessment of autoimmunity in patients with chronic urticaria. J Allergy Clin Immunol 99:461–465PubMedCrossRef
18.
go back to reference Soundararajan S, Kikuchi K, Joseph K, Kaplan AP (2005) Functional assessment of pathogenic IgG subclasses in chronic autoimmune urticaria. J Allergy Clin Immunol 115:815–821PubMedCrossRef Soundararajan S, Kikuchi K, Joseph K, Kaplan AP (2005) Functional assessment of pathogenic IgG subclasses in chronic autoimmune urticaria. J Allergy Clin Immunol 115:815–821PubMedCrossRef
19.
go back to reference Fiebiger E, Hammaerschmid F, Stingl G, Maurer D (1998) Anti-Fcepsilon R1 autoantibodies in autoimmune-mediated disorders. Identification of a structure function relationship. J Clin Invest 101:243–251PubMedCrossRef Fiebiger E, Hammaerschmid F, Stingl G, Maurer D (1998) Anti-Fcepsilon R1 autoantibodies in autoimmune-mediated disorders. Identification of a structure function relationship. J Clin Invest 101:243–251PubMedCrossRef
20.
go back to reference Ferrer M, Nakazawa K, Kaplan AP (1999) Complement dependence of histamine release in chronic urticaria. J Allergy Clin Immunol 104:169–172PubMedCrossRef Ferrer M, Nakazawa K, Kaplan AP (1999) Complement dependence of histamine release in chronic urticaria. J Allergy Clin Immunol 104:169–172PubMedCrossRef
21.
go back to reference Kikuchi Y, Kaplan AP (2002) A role for C5a in augmenting IgG dependent histamine release from basophils in chronic urticaria. J Allergy Clin Immunol 109:114–118PubMedCrossRef Kikuchi Y, Kaplan AP (2002) A role for C5a in augmenting IgG dependent histamine release from basophils in chronic urticaria. J Allergy Clin Immunol 109:114–118PubMedCrossRef
22.
go back to reference Greaves MW, Plummer VM, McLaughlan P, Stanworth DR (1974) Serum and cell bound IgE in chronic urticaria. Clin Allergy 4:265–271PubMedCrossRef Greaves MW, Plummer VM, McLaughlan P, Stanworth DR (1974) Serum and cell bound IgE in chronic urticaria. Clin Allergy 4:265–271PubMedCrossRef
23.
go back to reference Sabroe RA, Francis DM, Barr RM et al (1998) Anti-Fcepsilon R1 autoantibodies and basophil histamine releasability in chronic idiopathic urticaria. J Allergy Clin Immunol 102:651–658PubMedCrossRef Sabroe RA, Francis DM, Barr RM et al (1998) Anti-Fcepsilon R1 autoantibodies and basophil histamine releasability in chronic idiopathic urticaria. J Allergy Clin Immunol 102:651–658PubMedCrossRef
24.
go back to reference Confino-Cohen R, Aharoni D, Goldberg A et al (2002) Evidence for aberrant regulation of the P21 Ras pathway in PBMCC’s of patients with chronic urticaria. J Allergy Clin Immunol 109:349–356PubMedCrossRef Confino-Cohen R, Aharoni D, Goldberg A et al (2002) Evidence for aberrant regulation of the P21 Ras pathway in PBMCC’s of patients with chronic urticaria. J Allergy Clin Immunol 109:349–356PubMedCrossRef
25.
go back to reference Grattan CEH, Francis DM, Hide M, Greaves MW (1991) Detection of circulating histamine releasing autoantibodies with functional properties of anti-IgE in chronic urticaria. Clin Exp Allergy 21:695–704PubMedCrossRef Grattan CEH, Francis DM, Hide M, Greaves MW (1991) Detection of circulating histamine releasing autoantibodies with functional properties of anti-IgE in chronic urticaria. Clin Exp Allergy 21:695–704PubMedCrossRef
26.
go back to reference Sabroe RA, Poon E, Orchard GE et al (1999) Cutaneous inflammatory cell infiltrate in chronic idiopathic urticaria: comparison of patients with and without anti-Fc epsilon R1 or anti-IgE autoantibodies. J Allergy Clin Immunol 103:484–493PubMedCrossRef Sabroe RA, Poon E, Orchard GE et al (1999) Cutaneous inflammatory cell infiltrate in chronic idiopathic urticaria: comparison of patients with and without anti-Fc epsilon R1 or anti-IgE autoantibodies. J Allergy Clin Immunol 103:484–493PubMedCrossRef
27.
go back to reference Grattan CEH, Wallington TB, Warin RP et al (1986) A serological mediator in chronic idiopathic urticaria—a clinical immunological and histological evaluation. Br J Dermatol 114:583–590PubMedCrossRef Grattan CEH, Wallington TB, Warin RP et al (1986) A serological mediator in chronic idiopathic urticaria—a clinical immunological and histological evaluation. Br J Dermatol 114:583–590PubMedCrossRef
28.
go back to reference Sabroe RA, Grattan CEH, Francis DM et al (1999) The autologous serum skin test: a screening test for autoantibodies in chronic idiopathic urticaria. Br J Dermatol 140:446–452PubMedCrossRef Sabroe RA, Grattan CEH, Francis DM et al (1999) The autologous serum skin test: a screening test for autoantibodies in chronic idiopathic urticaria. Br J Dermatol 140:446–452PubMedCrossRef
29.
go back to reference Sabroe RA, Fiebiger E, Francis DM et al (2002) Classification of anti-FcɛR1 and anti-IgE autoantibodies in chronic urticaria and correlation with disease activity. J Allergy Clin Immunol 40:492–499CrossRef Sabroe RA, Fiebiger E, Francis DM et al (2002) Classification of anti-FcɛR1 and anti-IgE autoantibodies in chronic urticaria and correlation with disease activity. J Allergy Clin Immunol 40:492–499CrossRef
30.
go back to reference Asero R, Tedeschi A, Lorini M et al (2001) Chronic urticaria: novel clinical and serological aspects. Clin Exp Allergy 31:1105–1110PubMedCrossRef Asero R, Tedeschi A, Lorini M et al (2001) Chronic urticaria: novel clinical and serological aspects. Clin Exp Allergy 31:1105–1110PubMedCrossRef
31.
go back to reference Grattan CEH, Sabroe RA, Greaves MW (2002) Chronic urticaria. J Amer Acad Dermatol 46:645–657CrossRef Grattan CEH, Sabroe RA, Greaves MW (2002) Chronic urticaria. J Amer Acad Dermatol 46:645–657CrossRef
32.
33.
go back to reference Kaplan AP (2004) Chronic urticaria: pathogenesis and treatment. J Allergy Clin Immunol 114:465–474PubMedCrossRef Kaplan AP (2004) Chronic urticaria: pathogenesis and treatment. J Allergy Clin Immunol 114:465–474PubMedCrossRef
34.
go back to reference Ferrer M, Luquin E, Kaplan AP (2003) IL-3 effect on basophils histamine release upon stimulation with chronic urticaria sera. Allergy 58:802–807PubMedCrossRef Ferrer M, Luquin E, Kaplan AP (2003) IL-3 effect on basophils histamine release upon stimulation with chronic urticaria sera. Allergy 58:802–807PubMedCrossRef
35.
go back to reference Zweiman B, Valenzano M, Atkins PC et al (1996) Characteristics of histamine releasing activity in the sera of patients with chronic idiopathic urticaria. J Allergy Clin Immunol 98:89–98PubMedCrossRef Zweiman B, Valenzano M, Atkins PC et al (1996) Characteristics of histamine releasing activity in the sera of patients with chronic idiopathic urticaria. J Allergy Clin Immunol 98:89–98PubMedCrossRef
36.
go back to reference Ferrer M, Kinet JP, Kaplan A (1998) Comparative studies of functional and binding assays for IgG anti-Fc(epsilon) R1 alpha (alpha subunit) in chronic urticaria. J Allergy Clin Immunol 101:672–676PubMedCrossRef Ferrer M, Kinet JP, Kaplan A (1998) Comparative studies of functional and binding assays for IgG anti-Fc(epsilon) R1 alpha (alpha subunit) in chronic urticaria. J Allergy Clin Immunol 101:672–676PubMedCrossRef
37.
go back to reference Kikuchi Y, Kaplan AP (2001) Mechanisms of autoimmjune activation of basophils in chronic urticaria. J Allergy Clin Immunol 107:1056–1062PubMedCrossRef Kikuchi Y, Kaplan AP (2001) Mechanisms of autoimmjune activation of basophils in chronic urticaria. J Allergy Clin Immunol 107:1056–1062PubMedCrossRef
38.
go back to reference Brunetti L, Francavilla R, Miniello VL et al (2004) High prevalence of autoimmune urticaria in children with chronic urticaria. J Allergy Clin Immunol 114:922–927PubMedCrossRef Brunetti L, Francavilla R, Miniello VL et al (2004) High prevalence of autoimmune urticaria in children with chronic urticaria. J Allergy Clin Immunol 114:922–927PubMedCrossRef
39.
go back to reference Horn MP, Pachlopnik JM, Vogel M et al (2001) Conditional autoimmunity mediated by human natural anti-FcɛR1α autoantibodies. FASEB J 15:2268–2274PubMedCrossRef Horn MP, Pachlopnik JM, Vogel M et al (2001) Conditional autoimmunity mediated by human natural anti-FcɛR1α autoantibodies. FASEB J 15:2268–2274PubMedCrossRef
40.
go back to reference Pachlopnik JM, Horn MP, Fux M et al (2004) Natural FcɛR1α autoantibodies may interfere with diagnostic tests for chronic urticaria. J Autoimmun 22:43–51PubMedCrossRef Pachlopnik JM, Horn MP, Fux M et al (2004) Natural FcɛR1α autoantibodies may interfere with diagnostic tests for chronic urticaria. J Autoimmun 22:43–51PubMedCrossRef
41.
go back to reference Horn MP Gerster T, Ochensberger B et al (1999) Human anti-FcɛR1α autoantibodies isolated from healthy donors cross react with tetanus toxoid. Eur J Immunol 29:1139–1148PubMedCrossRef Horn MP Gerster T, Ochensberger B et al (1999) Human anti-FcɛR1α autoantibodies isolated from healthy donors cross react with tetanus toxoid. Eur J Immunol 29:1139–1148PubMedCrossRef
42.
go back to reference Kozel MMA, Bossuyt PMM, Mekkes JR et al (2003) Laboratory tests and identified diagnoses in patients with physical and chronic urticaria and angioedema: a systematic review. J Amer Acad Dermatol 48:409-416CrossRef Kozel MMA, Bossuyt PMM, Mekkes JR et al (2003) Laboratory tests and identified diagnoses in patients with physical and chronic urticaria and angioedema: a systematic review. J Amer Acad Dermatol 48:409-416CrossRef
43.
go back to reference Zuberbier T, Bindslev-Jensen C, Canonica W et al (2006) EAACI/GA2LEN/EDF guideline: definition, classification and diagnosis of urticaria. Allergy 61:321–331PubMedCrossRef Zuberbier T, Bindslev-Jensen C, Canonica W et al (2006) EAACI/GA2LEN/EDF guideline: definition, classification and diagnosis of urticaria. Allergy 61:321–331PubMedCrossRef
44.
go back to reference Soter NA (1977) Chronic urticaria as a manifestation of necrotizing venulitis. N Eng J Med 296:1440–1442CrossRef Soter NA (1977) Chronic urticaria as a manifestation of necrotizing venulitis. N Eng J Med 296:1440–1442CrossRef
45.
go back to reference O’Donnell BF, Francis DM, Swana GT et al (2005) Thyroid autoimmunity in chronic urticaria. Brit J Dermatol 153:331–335CrossRef O’Donnell BF, Francis DM, Swana GT et al (2005) Thyroid autoimmunity in chronic urticaria. Brit J Dermatol 153:331–335CrossRef
46.
go back to reference Leznoff A, Josse RG, Denberg J, Dolovich J (1983) Association of chronic urticaria and angioedema with thyroid autoimmunity. Arch Dermatol 119:636–640PubMedCrossRef Leznoff A, Josse RG, Denberg J, Dolovich J (1983) Association of chronic urticaria and angioedema with thyroid autoimmunity. Arch Dermatol 119:636–640PubMedCrossRef
47.
go back to reference Kaplan AP, Finn A (1999) Autoimmunity and the etiology of chronic urticaria. Canad J Allergy Clin Immunol 4:286–292 Kaplan AP, Finn A (1999) Autoimmunity and the etiology of chronic urticaria. Canad J Allergy Clin Immunol 4:286–292
48.
go back to reference Greaves MW (2005) Antihistamines in dermatology. Skin Physiol Pharmacol 18:220–229CrossRef Greaves MW (2005) Antihistamines in dermatology. Skin Physiol Pharmacol 18:220–229CrossRef
49.
go back to reference Nelson HS, Reynolds R, Mason J (2000) Fexofenadine HCL is safe and effective for treatment of chronic idiopathic urticaria. Ann Allergy Asthma Immunol 84:517–522PubMedCrossRef Nelson HS, Reynolds R, Mason J (2000) Fexofenadine HCL is safe and effective for treatment of chronic idiopathic urticaria. Ann Allergy Asthma Immunol 84:517–522PubMedCrossRef
50.
go back to reference Versten J, Volkerts, ER, Von Ostenwijck AW et al (2003) Acute and subchronic effects of levocetirizine and diphenhydramine on memory functioning, psychomotor performance and mood. J Allergy Clin Immunol 111:623–627CrossRef Versten J, Volkerts, ER, Von Ostenwijck AW et al (2003) Acute and subchronic effects of levocetirizine and diphenhydramine on memory functioning, psychomotor performance and mood. J Allergy Clin Immunol 111:623–627CrossRef
51.
go back to reference Weiler J, Bloom JR, Woodworth GG et al (2000) Effects of fexofenadine, diphenhydramine and alcohol on driving performance. A randomized placebo-controlled trial in the Iowa driving simulator. Ann Int Med 132:354–363PubMed Weiler J, Bloom JR, Woodworth GG et al (2000) Effects of fexofenadine, diphenhydramine and alcohol on driving performance. A randomized placebo-controlled trial in the Iowa driving simulator. Ann Int Med 132:354–363PubMed
52.
go back to reference Bleehen S, Thomas SE, Greaves MW et al (1987) Cimetidine and chlorpheniramine in the treatment of chronic idiopathic urticaria: a multi-centre randomized double blind study. Br J Dermatol 117:81–88PubMedCrossRef Bleehen S, Thomas SE, Greaves MW et al (1987) Cimetidine and chlorpheniramine in the treatment of chronic idiopathic urticaria: a multi-centre randomized double blind study. Br J Dermatol 117:81–88PubMedCrossRef
53.
go back to reference Sackett DL, Rosenberg WMC, Gray JA et al (1996) Evidence based medicine: what it is and what it isn’t : its about integrating individual clinical expertise and the best external evidence. Br Med J 312:71–72 Sackett DL, Rosenberg WMC, Gray JA et al (1996) Evidence based medicine: what it is and what it isn’t : its about integrating individual clinical expertise and the best external evidence. Br Med J 312:71–72
54.
go back to reference Ellis MH (1998) Successful treatment of chronic urticaria with leukotriene antagonists. J Allergy Clin Immunol 102:876–877PubMedCrossRef Ellis MH (1998) Successful treatment of chronic urticaria with leukotriene antagonists. J Allergy Clin Immunol 102:876–877PubMedCrossRef
55.
go back to reference Bagenstose SE, Levin L, Bernstein JA (2004) The addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test results. J Allergy Clin Immunol 113:134–140PubMedCrossRef Bagenstose SE, Levin L, Bernstein JA (2004) The addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test results. J Allergy Clin Immunol 113:134–140PubMedCrossRef
56.
go back to reference Pacor ML, Di Lorenzo G, Corrocher R (2001) Efficacy of leukotriene receptor antagonist in chronic urticaria. A double-blind placebo-controlled comparison of treatment with montelukast and cetirizine in patients with chronic urticaria with intolerance to food additive and/or salicylic acid. Clin Exp Allergy 31:1607–1614PubMedCrossRef Pacor ML, Di Lorenzo G, Corrocher R (2001) Efficacy of leukotriene receptor antagonist in chronic urticaria. A double-blind placebo-controlled comparison of treatment with montelukast and cetirizine in patients with chronic urticaria with intolerance to food additive and/or salicylic acid. Clin Exp Allergy 31:1607–1614PubMedCrossRef
57.
go back to reference Nettis E, Dambra P, D’Oronzio L et al (2001) Comparison of montelukast and fexofenadine for chronic idiopathic urticaria. Arch Dermatol 137:99–100PubMed Nettis E, Dambra P, D’Oronzio L et al (2001) Comparison of montelukast and fexofenadine for chronic idiopathic urticaria. Arch Dermatol 137:99–100PubMed
58.
go back to reference Perez C, Sanchez-Borges M (2001) Pretreatment with montelukast blocks NSAID-induced urticaria and angioedema. J Allergy Clin Immunol 108:1060–1061PubMedCrossRef Perez C, Sanchez-Borges M (2001) Pretreatment with montelukast blocks NSAID-induced urticaria and angioedema. J Allergy Clin Immunol 108:1060–1061PubMedCrossRef
59.
go back to reference Erbagci Z (2002) The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: a single-blind placebo-controlled crossover. J Allergy Clin Immunol 110:484–488PubMedCrossRef Erbagci Z (2002) The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: a single-blind placebo-controlled crossover. J Allergy Clin Immunol 110:484–488PubMedCrossRef
60.
go back to reference Di Lorenzo G, Pacor ML, Mansueto P et al (2004) Randomised placebo- controlled trial comparing desloratidine and montelukast in monotherapy and deslotatidine plus montelukast in combined therapy for chronic idiopathic urticaria. J Allergy Clin Immunol 114:619–625PubMedCrossRef Di Lorenzo G, Pacor ML, Mansueto P et al (2004) Randomised placebo- controlled trial comparing desloratidine and montelukast in monotherapy and deslotatidine plus montelukast in combined therapy for chronic idiopathic urticaria. J Allergy Clin Immunol 114:619–625PubMedCrossRef
61.
go back to reference Wechsler ME, Garbpestad E, Flier SR et al (1998) Pulmonary infiltrates, eosinophilia and cardiomyopathy following corticosteroid withdrawal in patients with asthma receiving zafirlukast. J Amer Med Ass 279:455–457CrossRef Wechsler ME, Garbpestad E, Flier SR et al (1998) Pulmonary infiltrates, eosinophilia and cardiomyopathy following corticosteroid withdrawal in patients with asthma receiving zafirlukast. J Amer Med Ass 279:455–457CrossRef
63.
go back to reference Wong E, Eftekhari N, Greaves MW, Milford Ward A (1987) Beneficial effects of danazol on symptoms and laboratory changes in cholinergic urticaria. Br J Dermatol 116:553–556PubMedCrossRef Wong E, Eftekhari N, Greaves MW, Milford Ward A (1987) Beneficial effects of danazol on symptoms and laboratory changes in cholinergic urticaria. Br J Dermatol 116:553–556PubMedCrossRef
64.
go back to reference Parsad D, Pandhi R, Juneja A (2001) Stanozolol in chronic urticaria: results of a double blind placebo controlled trial. J Dermatol 28:299–302PubMed Parsad D, Pandhi R, Juneja A (2001) Stanozolol in chronic urticaria: results of a double blind placebo controlled trial. J Dermatol 28:299–302PubMed
65.
go back to reference Kessel A, Bamberger E, Toubi E (2005) Tacrolimus in the treatment of severe chronic idiopathic urticaria: an open label prospective study. J Amer Acad Dermatol 52:145–148CrossRef Kessel A, Bamberger E, Toubi E (2005) Tacrolimus in the treatment of severe chronic idiopathic urticaria: an open label prospective study. J Amer Acad Dermatol 52:145–148CrossRef
66.
go back to reference Grattan CEH, O’Donnell BF, Francis DM et al (2000) Randomised double blind study of cyclosporine in chronic idiopathic urticaria. Br J Dermatol 143:365–372PubMedCrossRef Grattan CEH, O’Donnell BF, Francis DM et al (2000) Randomised double blind study of cyclosporine in chronic idiopathic urticaria. Br J Dermatol 143:365–372PubMedCrossRef
67.
go back to reference O’Donnell BF, Barr RM, Black AK et al (1998) Intravenous immunoglobulin in chronic urticaria. Br J Dermatol 138:101–106PubMedCrossRef O’Donnell BF, Barr RM, Black AK et al (1998) Intravenous immunoglobulin in chronic urticaria. Br J Dermatol 138:101–106PubMedCrossRef
68.
go back to reference Grattan CEH, Francis DM, Slater NGP et al (1992) Plasmapheresis for severe unremitting chronic urticaria. Lancet 339:1078–1080PubMedCrossRef Grattan CEH, Francis DM, Slater NGP et al (1992) Plasmapheresis for severe unremitting chronic urticaria. Lancet 339:1078–1080PubMedCrossRef
Metadata
Title
Chronic Urticaria: Recent Advances
Authors
Malcolm W. Greaves
Kian Teo Tan
Publication date
01-10-2007
Publisher
Humana Press Inc
Published in
Clinical Reviews in Allergy & Immunology / Issue 1-2/2007
Print ISSN: 1080-0549
Electronic ISSN: 1559-0267
DOI
https://doi.org/10.1007/s12016-007-0038-3

Other articles of this Issue 1-2/2007

Clinical Reviews in Allergy & Immunology 1-2/2007 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.